Orgovyx 120 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9FQ4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,841
Award facts
- Contract value 100% obligated
- $5,840.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,840.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets (30-count units) on December 12, 2025, with an ultimate completion date of January 6, 2026. This is a non-set-aside competitive award issued to the major pharmaceutical distributor's Corporate Office division, with performance at the company's Conshohocken, Pennsylvania headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a critical federal pharmaceutical vendor that supplies comprehensive medical products across multiple therapeutic domains to military healthcare systems and other government agencies. The SPE2DX prime indefinite delivery vehicle serves as a global pharmaceutical support contract enabling the company to fulfill diverse medical procurement needs including specialty medications, brand-name and generic drugs, vaccines, and associated medical supplies for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers. This particular delivery order for ORGOVYX—a prostate cancer treatment—exemplifies the company's role in supporting military healthcare programs through the DLA's Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26F9FQ4?
SPE2DR26F9FQ4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26F9FQ4 worth?
The government has obligated $5,841 on SPE2DR26F9FQ4.
Is contract SPE2DR26F9FQ4 an order under another contract?
Yes. SPE2DR26F9FQ4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9FQ4 competed?
The extent of competition for SPE2DR26F9FQ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award